Abstract
In many countries, including New Zealand, lung cancer causes disproportionate health loss to indigenous populations such as Mǟori. Screening by low dose CT scan (LDCT) has emerged as a promising intervention to reduce lung cancer mortality among high-risk populations but reported incremental cost-effectiveness ratios (ICERs) have varied widely. Furthermore, these analyses rarely examine cost-effectiveness or impacts on health inequalities for indigenous populations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
